Cd161-clec2d
Prostate cancer nk interaction Cd103+cd11b+ mucosal classical dendritic cells initiate long-term Figure 1 from overexpression of llt1 (ocil, clec2d) on prostate cancer
Figure 1 from Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer
Molecular basis for llt1 protein recognition by human cd161 protein Prostate ocil overexpression inhibits nk cd161 mediated cells Lysis blocking negative mediated interaction killer triple enhances cells breast cancer cell natural
Cd63 antibody immunofluorescence fitc ma1 mem monoclonal icc
Cd63 antibody, fitc (ma1-19602)Figure 1 from overexpression of llt1 (ocil, clec2d) on prostate cancer Nk prostate cell inhibits interaction killing mediated cells overexpression cancer throughCd161 basis molecular recognition binding.
(pdf) overexpression of llt1 (ocil, clec2d) on prostate cancer cells(pdf) blocking llt1 (clec2d, ocil)-nkrp1a (cd161) interaction enhances Cd11b cd103 cells dendritic mucosal.
(PDF) Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer cells
Figure 1 from Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer
Figure 1 from Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer
CD103+CD11b+ mucosal classical dendritic cells initiate long-term
Molecular Basis for LLT1 Protein Recognition by Human CD161 Protein
CD63 Antibody, FITC (MA1-19602)